blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2968673

EP2968673 - METHOD FOR DECELLULARIZATION OF TISSUE GRAFTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.04.2022
Database last updated on 17.05.2024
FormerThe patent has been granted
Status updated on  30.04.2021
FormerGrant of patent is intended
Status updated on  17.12.2020
FormerExamination is in progress
Status updated on  17.11.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024 [2024/22]
Applicant(s)For all designated states
University of Florida Research Foundation, Inc.
223 Grinter Hall
Gainesville, FL 32611 / US
[2016/03]
Inventor(s)01 / MUIR, David, F.
7125 Nw 47th Court
Gainesville, FL 32606 / US
 [2016/03]
Representative(s)Krauss, Jan
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
[2021/22]
Former [2016/03]Krauss, Jan
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Patentanwälte Rechtsanwälte
Pettenkoferstrasse 20-22
80336 München / DE
Application number, filing date14763757.317.03.2014
[2016/03]
WO2014US30688
Priority number, dateUS201361794012P15.03.2013         Original published format: US 201361794012 P
[2016/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014145854
Date:18.09.2014
Language:EN
[2014/38]
Type: A1 Application with search report 
No.:EP2968673
Date:20.01.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 18.09.2014 takes the place of the publication of the European patent application.
[2016/03]
Type: B1 Patent specification 
No.:EP2968673
Date:02.06.2021
Language:EN
[2021/22]
Search report(s)International search report - published on:KR18.09.2014
(Supplementary) European search report - dispatched on:EP30.09.2016
ClassificationIPC:A61L27/38, A61F2/02, A01N1/00
[2016/03]
CPC:
A61L27/3687 (EP,KR,US); A61L27/3633 (US); A61L27/3675 (US);
A61L27/54 (US); C12N5/0081 (KR); A61L2430/32 (US);
A61L2430/40 (US); C12N2509/00 (KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/03]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ENTZELLULARISIERUNGSVERFAHREN VON GEWEBETRANSPLANTATEN[2016/03]
English:METHOD FOR DECELLULARIZATION OF TISSUE GRAFTS[2016/03]
French:PROCÉDÉ DE DÉCELLULARISATION DE GREFFES TISSULAIRES[2016/03]
Entry into regional phase15.09.2015National basic fee paid 
15.09.2015Search fee paid 
15.09.2015Designation fee(s) paid 
15.09.2015Examination fee paid 
Examination procedure15.09.2015Examination requested  [2016/03]
27.04.2017Amendment by applicant (claims and/or description)
20.11.2017Despatch of a communication from the examining division (Time limit: M06)
03.04.2018Reply to a communication from the examining division
19.06.2019Despatch of a communication from the examining division (Time limit: M04)
29.10.2019Reply to a communication from the examining division
18.12.2020Communication of intention to grant the patent
26.04.2021Fee for grant paid
26.04.2021Fee for publishing/printing paid
26.04.2021Receipt of the translation of the claim(s)
Divisional application(s)EP21177221.5  / EP3928806
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.11.2017
Opposition(s)03.03.2022No opposition filed within time limit [2022/19]
Fees paidRenewal fee
10.03.2016Renewal fee patent year 03
10.03.2017Renewal fee patent year 04
13.03.2018Renewal fee patent year 05
13.03.2019Renewal fee patent year 06
24.03.2020Renewal fee patent year 07
23.03.2021Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.03.2014
AL02.06.2021
CY02.06.2021
CZ02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
MC02.06.2021
MK02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SI02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IS02.10.2021
PT04.10.2021
[2024/22]
Former [2024/20]HU17.03.2014
AL02.06.2021
CY02.06.2021
CZ02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
MC02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SI02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IS02.10.2021
PT04.10.2021
Former [2024/18]HU17.03.2014
AL02.06.2021
CZ02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
MC02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SI02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IS02.10.2021
PT04.10.2021
Former [2022/47]AL02.06.2021
CZ02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
MC02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SI02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IS02.10.2021
PT04.10.2021
Former [2022/29]AL02.06.2021
CZ02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SI02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IS02.10.2021
PT04.10.2021
Former [2022/26]AL02.06.2021
CZ02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IS02.10.2021
PT04.10.2021
Former [2022/10]CZ02.06.2021
EE02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
IS02.10.2021
PT04.10.2021
Former [2022/09]CZ02.06.2021
FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
NL02.06.2021
PL02.06.2021
RO02.06.2021
RS02.06.2021
SE02.06.2021
SK02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
PT04.10.2021
Former [2022/07]FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
NL02.06.2021
PL02.06.2021
RS02.06.2021
SE02.06.2021
SM02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
Former [2021/52]FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
PL02.06.2021
RS02.06.2021
SE02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
Former [2021/51]FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
RS02.06.2021
SE02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
Former [2021/49]FI02.06.2021
HR02.06.2021
LT02.06.2021
LV02.06.2021
SE02.06.2021
BG02.09.2021
NO02.09.2021
GR03.09.2021
Former [2021/47]FI02.06.2021
LT02.06.2021
BG02.09.2021
Former [2021/46]FI02.06.2021
LT02.06.2021
Documents cited:Search[XI]US2005043819  (SCHMIDT CHRISTINE [US], et al) [X] 1,2,4-15 * paragraphs [0027] , [0031] , [0035]; example -; claim - * [I] 3;
 [X]  - Hudson, "Optimized acellular nerve graft is immunologically tolerated and supports regeneration", (20040101), URL: http://online.liebertpub.com/doi/pdf/10.1089/ten.2004.10.1641, (20160919), XP055303823 [X] 1,2,4-15 * the whole document *

DOI:   http://dx.doi.org/10.1089/ten.2004.10.1641
 [X]  - Xin-Long Ma ET AL, "Biomechanical properties of peripheral nerve after acellular treatment", Chinese medical journal, China, doi:10.3760/cma.j.issn.0366-6999.2011.23.017, (20111201), page 3925, URL: http://124.205.33.103:81/ch/reader/create_pdf.aspx?file_no=2011112939984720&flag=1&year_id=2011&quarter_id=23, XP055281826 [X] 1,2,4-15 * the whole document *

DOI:   http://dx.doi.org/10.3760/cma.j.issn.0366-6999.2011.23.017
International search[Y]US2005043819  (SCHMIDT CHRISTINE [US], et al);
 [A]CN101095963  (CHINESE PLA GENERAL HOSPITAL [CN]);
 [A]US2011195107  (MIN BYOUNG-HYUN [KR], et al);
 [X]  - "Thermo Scientific Pierce Cell Lysis Technical Handbook", THERMOSCIENTIFIC, (2008), XP008180655
 [A]  - MOORE, A. M. ET AL., "Acellular nerve allografts in peripheral nerve regeneration: A comparative study", MUSCLE & NERVE, (201108), vol. 44, no. 2, pages 221 - 234, XP055279489

DOI:   http://dx.doi.org/10.1002/mus.22033
 [A]  - KVIST, M. ET AL., "Regeneration in, and properties of, extracted peripheral nerve allografts and xenografts", JOURNAL OF PLASTIC SURGERY AND HAND SURGERY, (201106), vol. 45, no. 3, pages 122 - 128, XP008180645
 [A]  - MA, X.-L. ET AL., "Biomechanical properties of peripheral nerve after acellular treatment", CHINESE MEDICAL JOURNAL, (201112), vol. 124, no. 23, pages 3925 - 3929, XP055281826

DOI:   http://dx.doi.org/10.3760/cma.j.issn.0366-6999.2011.23.017
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.